Herantis Pharma’s financial year is the calendar year. During the year, the company publishes an Annual Financial Statements Release and one Interim Report related to accounting period’s first six months. The Financial Statements and Interim Reports will be released around at 9.00 a.m. (Finnish time) on the given dates.
|5-6 Feb 2018||Meet Herantis Pharma at Biotech and Money in London|
|31 Jan – 1 Mar 2018||Silent period|
|31 Jan – 1 Mar 2018||Closed window period|
|2 Mar 2018||Financial statements release on 2017|
|20 Mar 2018||Annual Report published for 2018|
|21 Mar 2018||Company presentation for Espoon osakesäästäjät|
|27 Mar 2018||Company presentation for Turun osakesäästäjät|
|11 Apr 2018||Annual General Meeting|
|30 Jul – 28 Aug 2018||Silent period|
|30 Jul – 28 Aug 2018||Closed window period|
|29 Aug 2018||Interim report release on January-June 2018|
During the Closed window period, trading of Herantis Pharma shares or derivatives is forbidden for the Insider group.